ERCC2 and cancer: Both AA and AG genotypes in XPD rs1799793 were strongly associated with increasing cancer risk in males (OR 6.92, 95 % CI 4.61–10.36; OR 1.92, 95 % CI 1.42–2.62), whereas in females there appeared to be an association with homozygosity but no relationship with heterozygosity.